New Key Statistics Module, Z-Score and F-Score
OTCPK:RGBP Key Ratios
| Market Cap $ M | 1.08 |
| Enterprise Value $ M | 1.74 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 4.01 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.26 |
| Beneish M-Score | -5.5 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -151.60 |
| EV-to-EBIT | -1.74 |
| EV-to-EBITDA | -1.74 |
| PEG | -- |
| Shares Outstanding M | 4.51 |
| Net Margin (%) | -368.22 |
| Operating Margin % | -165.68 |
| Pre-tax Margin (%) | -392.80 |
| Quick Ratio | 0.03 |
| Current Ratio | 0.03 |
| ROA % (ttm) | -391.44 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -10.65 |
| Dividend Yield % | -- |
| Altman Z-Score | -219.01 |
RGBP Number of Guru Trades
RGBP Volume of Guru Trades
Gurus Latest Trades with OTCPK:RGBP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RGBP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Regen BioPharma Inc Insider Transactions
No Available Data
News about OTCPK:RGBP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers